Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors

Cancer Research

Volumn 67, Issue 6, 2007, Pages 2676-2684

  Zindy, Frederique ^a   Uziel, Tamar ^a   Ayrault, Olivier ^a   Calabrese, Christopher ^a   Valentine, Marc ^a   Rehg, Jerold E ^a   Gilbertson, Richard J ^a   Sherr, Charles J ^a   Roussel, Martine F ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 2C; NESTIN; PROTEIN P53; PROTEIN PATCHED 1; SONIC HEDGEHOG PROTEIN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CARCINOGENESIS; CEREBELLUM; CHROMOSOME 6; CHROMOSOME REARRANGEMENT; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE INTERACTION; GENE MUTATION; GENOMIC INSTABILITY; IONIZING RADIATION; MEDULLOBLASTOMA; MOUSE; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPECTRAL KARYOTYPING; STEM CELL; TRISOMY;

ALLELES; ANIMALS; CEREBELLAR NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P18; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, P53; INTEGRASES; INTERMEDIATE FILAMENT PROTEINS; MEDULLOBLASTOMA; MICE; MICE, NUDE; NERVE TISSUE PROTEINS; NEURONS; PRECANCEROUS CONDITIONS; RECEPTORS, CELL SURFACE; TRISOMY;

EID: 34047263220     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3418     Document Type: Article

References (35)

1. Kleihues PC, Cavenee WK. World Health Organization Classification of Tumours: Pathology and Genetics: Tumours of the Nervous System-IARC Press; 2000. p. 129-48.
2. Gilbertson RJ. Medulloblastoma: signalling a change in treatment Lancet Oncol 2004;5:209-18.
3. Fogarty MP, Kessler JD, Wechsler-Reya RJ. Morphing into cancer: the role of developmental signaling pathways in brain tumor formation. J Neurobiol 2005; 64:458-75.
4. Fan X, Matsui W, Khaki L, et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 2006;66:7445-52.
5. Hallahan AR, Pritchard JI, Hansen S, et al. The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res 2004;64:7794-800.
6. Thompson MC, Fuller C, Hogg TL, et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 2006;24: 1924-31.
7. Marino S. Medulloblastoma: developmental mechanisms out of control. Trends Mol Med 2005;11:17-22.
8. Frank AJ, Hernan R, Hollander A, et al. The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma. Brain Res Mol Brain Res 2004;121:137-40.
9. Wang VY, Zoghbi HY. Genetic regulation of cerebellar development. Nat Rev Neurosci 2001;2:484-91.
10. Goldowitz D, Hamre K. The cells and molecules that make a cerebellum. Trends Neurosci 1998;21:375-82.
11. Wechsler-Reya RJ, Scott MP. The developmental biology of brain tumors. Annu Rev Neurosci 2001;24:385-428.
12. Read TA, Hegedus B, Wechsler-Reya R, Gutmann DH. The neurobiology of neurooncology. Ann Neurol 2006; 60:3-11.
13. Uziel T, Zindy F, Xie S, et al. The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes Dev 2005;19:2656-67.
14. Zindy F, Nilsson LM, Nguyen L, et al. Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice. Cancer Res 2003;63:5420-7.
15. Snijders AM, Nowak NJ, Huey B, et al. Mapping segmental and sequence variations among laboratory mice using BAC array CGH. Genome Res 2005;15: 302-11.
16. Nowak NJ, Snijders A, Conroy J, Albertson D. The BAC resources. Curr Protocols Hum Genet 2005;4.13: 1-31.
17. Yang YH, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002;30:e15.
18. Hatten ME, Gao WQ, Morrison ME, Mason CA. The cerebellum: purification and coculture of identified cell populations. In: Banker G, Goslin K, editors. Culturing nerve cells. Cambridge (MA): The MIT Press; 1998. p. 419-59.
19. Lee Y, Miller HL, Jensen P, et al. A molecular fingerprint for medulloblastoma. Cancer Res 2003;63: 5428-37.
20. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
21. Goodrich LV, Milenkovic L, Higgins KM, Scott MP. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 1997;277:1109-13.
22. Wetmore C, Eberhart DE, Curran T. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res 2001;61:513-6.
23. Bai F, Pei XH, Godfrey VL, Xiong Y. Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis. Mol Cell Biol 2003;23: 1269-77.
24. Lee Y, McKinnon PJ. DNA Ligase IV suppresses medulloblastoma formation. Cancer Res 2002;62: 6395-9.
25. Tong WM, Ohgaki H, Huang H, et al. Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice. Am J Pathol 2003;162:343-52.
26. Yan CT, Kaushal D, Murphy M, et al. XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice. Proc Natl Acad Sci U S A 2006;103:7378-83.
27. Shakhova O, Leung C, van ME, Berns A, Marino S. Lack of Rb and p53 delays cerebellar development and predisposes to large cell anaplastic medulloblastoma through amplification of N-Myc and Ptch2. Cancer Res 2006;66:5190-200.
28. Kenney AM, Rowitch DH. Sonic hedgehog promotes G(1) cyclin expression and sustained cell cycle progression in mammalian neuronal precursors. Mol Cell Biol 2000;20:9055-67.
29. Aldosari N, Bigner SH, Burger PC, et al. MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group. Arch Pathol Lab Med 2002;126:540-4.
30. Garson JA, Pemberton LF, Sheppard PW, et al. N-myc gene expression and oncoprotein characterisation in medulloblastoma. Br J Cancer 1989;59:889-94.
31. Knoepfler PS, Kenney AM. Neural precursor cycling at sonic speed: N-Myc pedals, GSK-3 brakes. Cell Cycle 2006;5:47-52.
32. Knoepfler PS, Cheng PF, Eisenman RN. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev 2002;16:2699-712.
33. Oliver TG, Grasfeder LL, Carroll AL, et al. Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proc Natl Acad Sci U S A 2003; 100:7331-6.
34. Hatton BA, Knoepfler PS, Kenney AM, et al. N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth. Cancer Res 2006;66:8655-61.
35. Pogoriler J, Millen K, Utset M, Du W. Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation. Development 2006;133: 3929-37.